I have three observations regarding the Jose Guillen HGH investigation:
- I am shocked, shocked that Guillen is tied up with HGH. Oh wait, no I’m not. Not one bit. All that’s missing now is for Dayton Moore to waltz in and give him another $36 million contract as soon as this thing is over;
- If Guillen was using HGH, can we finally dispense with the fantasy that HGH is performance enhancing? Short of that, can he get out of a 50 game suspension here, seeing as though the stuff he was being sent was obviously the HGH equivalent of oregano in a dime bag?
Oh well. Assuming this plays out how we think it will, Mike Morgan, Matt Stairs, and Ron Villone’s record for most franchises played for in a career is safe. Jose will likely end with ten, falling two short of those dudes. Sad, really.
Rays manager Kevin Cash said that pitcher Nathan Eovaldi will join the starting rotation on Monday or Tuesday to face the Athletics, Marc Topkin of the Tampa Bay Times reports. Eovaldi’s rehab outing with Triple-A Durham went well, even though he gave up eight runs in four innings.
Eovaldi, 28, hasn’t pitched in the majors since 2016 after undergoing Tommy John surgery. He had arthroscopic surgery in March to remove loose bodies in his elbow. It’s been a long road back. Knowing Eovaldi needed to recover from surgery, the Rays signed him to a one-year, $2 million contract in 2017 that included a $2 million club option for 2018 that they exercised last November.
When Eovaldi last pitched, he ranked among baseball’s hardest throwers, particularly among starters. He averaged 97.1 MPH on his fastball in 2016. Among starters who racked up at least 100 innings that season, only the Mets’ Noah Syndergaard had a higher average velocity (97.9 MPH). It remains to be seen if he still has that velocity after undergoing two procedures on his elbow.
The Rays will be glad to have Eovaldi back. The club has sustained injuries to Jake Faria, Yonny Chirinos, and Jose De Leon.